VGM & ASSOCIATESHealthcare MSO
Full Menu Search

Take Action Today: Urge CMS to Pause and Re-Evaluate the Competitive Bidding Program

Published in Government Relations on October 24, 2025

Now is the time to raise our voices. With the formal announcement of the Competitive Bidding (CB) Program expected as early as the end of this month, we must act swiftly and decisively. Below are two key opportunities to engage with your U.S. Representative and encourage their support for a Congressional letter urging Centers for Medicare & Medicaid Services (CMS) to pause and reassess the CB Program. 

A new congressional letter led by Representatives Dan Meuser (R-PA) and Mariannette Miller-Meeks (R-IA) calls on the Department of Health and Human Services (HHS) and the CMS to pause the CB program and re-evaluate its provisions. The letter emphasizes the need to ensure the program aligns with the Administration’s goals of rebuilding American manufacturing, protecting Main Street businesses, and fostering innovation. 

The letter is addressed to Dr. Mehmet Oz, highlighting the urgency and importance of reassessing the CB program’s impact on the durable medical equipment (DME) industry and the broader healthcare ecosystem. 

Read the full letter here.

Take Action: Please contact your representative and urge them to support this effort by signing the letter. Instruct them to reach out directly to Rep. Meuser’s or Rep. Miller-Meeks’ offices to express your support or ask questions. AAHomecare shared this call to action yesterday along with valuable resources and guidance to help you engage effectively (see below). 

Help Recruit House Republicans to Join Sign-On Letter on CB Program 

Please Reach Out to GOP House Members as Soon as Possible! 

Reps. Dan Meuser and Mariannette Miller-Meeks are spearheading a sign-on letter for House Republicans asking CMS Administrator Dr. Mehmet Oz to prevent flawed provisions for a new round of the Competitive Bidding Program (CBP) from taking effect. 
 
The letter notes several major issues with the CBP provisions in the recent DMEPOS/Home Health Proposed Rule, including impacts on domestic medical product manufacturing, the addition of new product categories unsuited to the bidding program, and impacts on business.
 
The letter specifically asks CMS to withdraw expansion of the CBP into new product categories and to keep in place “guardrails established under the first Trump Administration—including use of the unadjusted 2015 fee schedules as the bid ceiling and payment at the clearing price—helped stabilize the market, maintain supplier viability, and protect patient access.” 
 
The letter proposes an alternate path that directs the Center for Medicare and Medicaid Innovation to “test an America First demonstration that rewards U.S.-made and allied-sourced products, incorporates modern fraud-prevention technologies, and evaluates outcomes before any nationwide expansion.” 
 
While we seek and embrace bipartisan support for reining in the numerous problematic issues with the proposed rule, this letter is specifically focused on enlisting House Republicans to weigh in with Dr. Oz. 
 
If you are represented in the House by a Republican, please share the letter with their staffer who handles healthcare issues and ask them to join the letter. You can share the link below with them (copy and paste) so they can see the letter and sign on: 
 
https://quill.senate.gov/letters/letter/30197/opt-in/view/5ec4607e-b349-4ea4-99ea-e9a1de08d379/ 
 
Note: you will not be able to open that link, but Congressional staff can access it to see and sign on to the letter. You can view the letter language here. 
 
CMS is expected to release Final Rule soon, so please take action today! 
 
Contact Gordon Barnes at gordonb@aahomecare.org if you need contact info for your healthcare staffer, or would like a PDF attachment of the letter to share, or for any other assistance in developing and delivering your message. 
 
Thank you for your advocacy as we continue to use every available channel to reach and influence the Administration on the flawed CBP proposal! 

Oct. 23, 2025 

Get Connected

Stay up-to-date on the latest resources and news provided by VGM & Associates.

Sign Up for Email

From Our Experts

Advocacy in Action: Texas DME Providers Stand Up For Patient Care thumbnail Advocacy in Action: Texas DME Providers Stand Up For Patient Care Texas DME providers are speaking out against proposed Medicaid reimbursement rate cuts that threaten access to essential medical equipment for vulnerable patients. At a recent public hearing, voices from across the state shared powerful stories about the real-world impact of these cuts—some as high as 85%. The Shutdown Has Ended—Now It's Time To Take Action thumbnail The Shutdown Has Ended—Now It's Time To Take Action The recent government shutdown created uncertainty across the healthcare landscape, and the DMEPOS community was no exception. In the weeks ahead, critical decisions will shape the future of our industry. By getting involved early—through advocacy, education, and collaboration—you can help ensure these policies support patients and providers rather than hinder them. Notably, the Continuing Resolution (CR) includes an extension of Medicare telehealth flexibilities through January 2026... New Issue Brief: Why Medicare's Competitive Bidding Program Needs Urgent Reform thumbnail New Issue Brief: Why Medicare's Competitive Bidding Program Needs Urgent Reform The Medicare competitive bidding program for durable medical equipment (DME) was designed to reduce costs—but it's failing patients and providers. A new issue brief from Pacific Research Institute and economist Wayne Winegarden highlights what changes are urgently needed. Champions of Change: DME Advocates Driving Real Change thumbnail Champions of Change: DME Advocates Driving Real Change Real change starts with real people. In this edition of Champions of Change, we're spotlighting two DME advocates who aren't just talking about problems—they're taking action. David Griffin and Gary Rench are showing us what it means to stand up for patients, providers, and the future of our industry. Join HME Industry Letter on CB Program to CMS Administrator Oz thumbnail Join HME Industry Letter on CB Program to CMS Administrator Oz HME suppliers, manufacturers, and distributors are invited to add their company's name to a letter to CMS Administrator Dr. Mehmet Oz regarding the Administration's DMEPOS/Home Health Proposed Rule that includes provisions for a new competitive bidding round. The letter specifically asks CMS to withdraw or delay the DMEPOS provisions in the Proposed Rule and re-engage with industry, patient, and clinical stakeholders to design an evidence-based, fraud-resistant, America-First framework. Legislative Momentum in the HME Industry: Key Updates & Action Items thumbnail Legislative Momentum in the HME Industry: Key Updates & Action Items The past few months have seen a surge of legislative activity in the home medical equipment sector, with several key developments shaping policy and advocacy efforts across the industry. From new bills introduced in Congress to formal comment submissions and stakeholder mobilization, these events reflect growing momentum around critical issues affecting providers and patients alike. This article offers a comprehensive recap of recent actions and outlines important next steps for those... VGM Submits Comments Regarding the Section 232 National Security Investigation On Medical Imports thumbnail VGM Submits Comments Regarding the Section 232 National Security Investigation On Medical Imports VGM has submitted formal comments to the U.S. Department of Commerce in response to its Section 232 National Security Investigation into the importation of personal protective equipment (PPE), medical consumables, and medical equipment and devices. Senate Backs DME Relief Act with Bipartisan Support thumbnail Senate Backs DME Relief Act with Bipartisan Support In a significant development for the durable medical equipment (DME) industry and Medicare beneficiaries, the U.S. Senate has introduced S.2951, the companion legislation to H.R. 2005, known as the DMEPOS Relief Act of 2025. The Senate bill is being led by Senator James Lankford (R-OK) and has gained bipartisan support with Senator Maggie Hassan (D-NH) joining as a co-sponsor.

Give your business an advantage over the competition.

Become a Member